A patent was issued to Professor Martin Yarmush and colleagues entitled, "Compositions and Methods of Functionally Enhanced In Vitro Culture System” (Patent number 9243221). The invention describes the development of a hepatocyte co-culture system in which the cells are highly metabolically active from the onset of culture, thereby allowing for immediate drug testing. This in vitro culture system is currently marketed by Hurel Corporation.